Please use this identifier to cite or link to this item: https://doi.org/10.1136/bmjgh-2023-012926
DC FieldValue
dc.title‘What we lacked was the courage to take decisions that differed from the rest of the world’: expert perspectives on the role of evidence in COVID-19 policymaking in Iraq
dc.contributor.authorAlshalah, Ali
dc.contributor.authorDouedari, Yazan
dc.contributor.authorHoward, Natasha
dc.date.accessioned2023-12-08T06:21:06Z
dc.date.available2023-12-08T06:21:06Z
dc.date.issued2023-11
dc.identifier.citationAlshalah, Ali, Douedari, Yazan, Howard, Natasha (2023-11). ‘What we lacked was the courage to take decisions that differed from the rest of the world’: expert perspectives on the role of evidence in COVID-19 policymaking in Iraq. BMJ Global Health 8 (11) : e012926-e012926. ScholarBank@NUS Repository. https://doi.org/10.1136/bmjgh-2023-012926
dc.identifier.issn2059-7908
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/246375
dc.description.abstract<jats:sec><jats:title>Introduction</jats:title><jats:p>Iraq reported its first COVID-19 case on 24 February 2020 and formed a national committee and advisory committees to support its response. While global experts have suggested that the COVID-19 pandemic provided an exceptional opportunity for advancing evidence-informed policymaking (EIPM), no research has examined this in Iraq. Therefore, this study aimed to examine evidence use in COVID-19 policymaking in Iraq.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>This qualitative study employed semi-structured interviews with 20 Iraqi policymakers and researchers. Data were analysed thematically in Arabic using inductive coding.</jats:p></jats:sec><jats:sec><jats:title>Findings</jats:title><jats:p>Participants described COVID-19 policy in Iraq as based on research conducted in other countries, with poor access and quality of routine data and lack of national research priorities and academic freedom as barriers to national research production. Most researchers influenced policy individually, with universities and other research bodies not seen as contributing to policy development. Public non-compliance could be traced to mistrust in both political and healthcare systems and became particularly problematic during the pandemic. Proposed strategies to increase national research production included dedicated funding, establishing communication and collaboration for research priority setting, and protection of academic freedom.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Sociopolitical and economic realities in Iraq were unsupportive of national or subnational evidence generation even before the COVID-19 pandemic, and government relied on international evidence and policy transfer rather than contextually informed EIPM. Strengthening evidence-informed infectious disease policymaking and policy transfer would thus require governmental focus on improving the quality and relevance of Iraqi research, engagement between researchers and policymakers, and processes of evidence use and policy transfer.</jats:p></jats:sec>
dc.publisherBMJ
dc.sourceElements
dc.typeArticle
dc.date.updated2023-12-08T05:02:08Z
dc.contributor.departmentDEAN'S OFFICE (SSH SCH OF PUBLIC HEALTH)
dc.description.doi10.1136/bmjgh-2023-012926
dc.description.sourcetitleBMJ Global Health
dc.description.volume8
dc.description.issue11
dc.description.pagee012926-e012926
dc.published.statePublished
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
2023.12.01L Al-Shaleh BMJGH.pdfPublished version381.49 kBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.